Freissmuth; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Freissmuth; Michael.The latest application filed is for "composition for the treatment of hepatic veno-occlusive disease".

Company Profile

3.7.14

Freissmuth; Michael - Vienna AT
Freissmuth; Michael - Wien AT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition for use in increasing engraftment efficacy of haematopoetic stem cells after transplantation Grant 10,226,465 - Freissmuth , et al.	2019-03-12
Method for enhancing engraftment of haematopoetic stem cells Grant 10,213,464 - Freissmuth , et al. Feb	2019-02-26
Composition for the treatment of cystic fibrosis Grant 10,086,001 - Freissmuth , et al. October 2, 2	2018-10-02
Composition For The Treatment Of Hepatic Veno-occlusive Disease App 20180021347 - Freissmuth; Michael ; et al.	2018-01-25
Composition For Use In Increasing Engraftment Efficacy Of Haematopoetic Stem Cells After Transplantation App 20180008606 - Freissmuth; Michael ; et al.	2018-01-11
Composition for the treatment of cystic fibrosis Grant 9,504,663 - Freissmuth , et al. November 29, 2	2016-11-29
Composition For The Treatment Of Cystic Fibrosis App 20160175319 - FREISSMUTH; Michael ; et al.	2016-06-23
Novel Composition For The Treatment Of Cystic Fibrosis App 20140018430 - Freissmuth; Michael ; et al.	2014-01-16
Method For Enhancing Engraftment Of Haematopoetic Stem Cells App 20130344038 - Freissmuth; Michael ; et al.	2013-12-26
Composition For The Treatment Of Cystic Fibrosis App 20120184622 - Freissmuth; Michael ; et al.	2012-07-19
Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface App 20100129343 - Freissmuth; Michael ; et al.	2010-05-27
Use Of A Preparation Based On An Antibody Directed Against A Tumor-associated Glycosylation App 20090181030 - LOIBNER; Hans ; et al.	2009-07-16
Use of a preparation based on an antibody directed against a tumor-associated glycosylation Grant 7,527,789 - Loibner , et al. May 5, 2	2009-05-05
Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface App 20090017006 - Freissmuth; Michael ; et al.	2009-01-15
Use of a compound for enhancing the expression of membrane proteins on the cell surface App 20070218043 - Freissmuth; Michael ; et al.	2007-09-20
Use of a compound for enhancing the expression of membrane proteins on the cell surface App 20060008454 - Freissmuth; Michael ; et al.	2006-01-12
Use of a preparation based on an antibody directed against a tumor-associated glycosylation App 20050226880 - Loibner, Hans ; et al.	2005-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.